Amazon launches six-month $6 prescriptions to Prime members

The new benefit program follows Walmart's announcement and seeks to disrupt the prescription drug market.

| More on:
woman chatting online on her macbook

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Amazon (NASDAQ: AMZN) announced today that it is launching a new prescription program for members of its Prime loyalty program, less than a day after Walmart (NYSE: WMT) said it was offering Walmart+ members a discounted prescription service as well.

Having acquired PillPack in 2018, Amazon has been looking to leverage its ability to buy prescription medicine in bulk and provide savings to members in a bid to take a large slice of the $360 billion prescription drug market.

Like the Walmart program, Amazon's new service is looking for patients who take just a small number of fairly common medicines, such as those used to treat high blood pressure and diabetes; they'll pay as little as $1 per month and receive a six-month supply.

Six months is typically longer than what insurance companies will pay for, so consumers could see real savings by enrolling in the healthcare prescription program. As Prime members, they'd also be entitled to receive free two-day delivery.

The new offer is an expansion of the Amazon Pharmacy benefit announced last month that allows Prime members to comparison shop for savings through its network of 60,000 pharmacies. It noted Prime members save 80% on generic medications and 40% on name-brand ones through Amazon Pharmacy.

Walmart just introduced Walmart+ RX, which also provides significant discounts on commonly used medications. It notes that members of Walmart+, a loyalty program the retailer launched to challenge Amazon Prime, can get some common medications free while saving up to 85% on others.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Rich Duprey has no position in any of the stocks mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

Modern accountant woman in a light business suit in modern green office with documents and laptop.
International Stock News

Microsoft stock: Time to double down?

Let's take a look.

Read more »

A man looking at his laptop and thinking.
International Stock News

Can $10,000 Invested in Nvidia Stock Today Turn Into $1 Million by 2035?

After soaring more than 800% between 2023 and 2024, Nvidia stock came to a screeching halt this year.

Read more »

A tech worker wearing a mask holds computer chip up to the camera.
International Stock News

Nvidia Just Became the World's Most Valuable Company. Here's What May Happen Next.

Nvidia has reclaimed its spot from Microsoft.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
International Stock News

The Tesla stock price just lost 14.8% and US$230 billion

A Trump-Musk fallout has tanked Tesla shares...

Read more »

A Tesla electric vehicle beingt charged
International Stock News

Prediction: Tesla Stock Won't Recover in 2025 (And Insiders Seem to Agree)

Many investors are losing confidence.

Read more »

A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
International Stock News

Prediction: Nvidia Will Beat the Market. Here's Why

The world's leading GPU maker is still a solid investment.

Read more »

A TV remote in focus with a screen of Netflix options in the background.
International Stock News

Can Netflix Stock Continue to Soar in 2025?

Some technology stocks have proven resilient through the ups and downs of 2025.

Read more »

A delivery man wearing a cap and smiling broadly delivers two boxes stacked on top of each other at the door of a female customer whose back can be seen at the edge of a doorway.
International Stock News

Why Amazon stock gained 11% in May

Let's take a look.

Read more »